- Home
- CRIS vs IRIX Comparison
CRIS vs IRIX Comparison
Compare CRIS & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRIS
- IRIX
- Stock Information
- Founded
- CRIS 2000
- IRIX 1989
- Country
- CRIS United States
- IRIX United States
- Employees
- CRIS N/A
- IRIX N/A
- Industry
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CRIS Health Care
- IRIX Health Care
- Exchange
- CRIS Nasdaq
- IRIX Nasdaq
- Market Cap
- CRIS 32.8M
- IRIX 27.5M
- IPO Year
- CRIS 2000
- IRIX 1996
- Fundamental
- Price
- CRIS $3.10
- IRIX $1.51
- Analyst Decision
- CRIS Strong Buy
- IRIX Hold
- Analyst Count
- CRIS 3
- IRIX 1
- Target Price
- CRIS $23.00
- IRIX $2.00
- AVG Volume (30 Days)
- CRIS 28.8K
- IRIX 30.3K
- Earning Date
- CRIS 02-25-2025
- IRIX 03-25-2025
- Dividend Yield
- CRIS N/A
- IRIX N/A
- EPS Growth
- CRIS N/A
- IRIX N/A
- EPS
- CRIS N/A
- IRIX N/A
- Revenue
- CRIS $10,259,000.00
- IRIX $48,431,000.00
- Revenue This Year
- CRIS N/A
- IRIX N/A
- Revenue Next Year
- CRIS N/A
- IRIX $5.44
- P/E Ratio
- CRIS N/A
- IRIX N/A
- Revenue Growth
- CRIS 0.44
- IRIX N/A
- 52 Week Low
- CRIS $2.86
- IRIX $1.27
- 52 Week High
- CRIS $17.49
- IRIX $3.65
- Technical
- Relative Strength Index (RSI)
- CRIS 41.55
- IRIX 38.42
- Support Level
- CRIS $3.10
- IRIX $1.46
- Resistance Level
- CRIS $3.32
- IRIX $1.60
- Average True Range (ATR)
- CRIS 0.18
- IRIX 0.05
- MACD
- CRIS -0.01
- IRIX -0.01
- Stochastic Oscillator
- CRIS 9.62
- IRIX 18.75
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About IRIX IRIDEX Corporation
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.